In keeping with this, we have demonstrated that the inhibition of the mTOR/AkT axis depends on PPAR-α activation, supporting its contribution in IBD-related angiogenesis and suggesting its protective role in inflammation-associated carcinogenesis. Here, AKT1 is linked to inflammatory bowel disease.